Endurance Wealth Management Inc. lowered its stake in shares of Danaher Co. (NYSE:DHR) by 0.8% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 68,167 shares of the conglomerate’s stock after selling 575 shares during the quarter. Danaher makes up about 1.8% of Endurance Wealth Management Inc.’s investment portfolio, making the stock its 12th largest holding. Endurance Wealth Management Inc.’s holdings in Danaher were worth $9,435,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds also recently added to or reduced their stakes in the company. Solstein Capital LLC acquired a new stake in shares of Danaher during the fourth quarter worth approximately $422,000. Bamco Inc. NY lifted its stake in Danaher by 8.1% during the fourth quarter. Bamco Inc. NY now owns 2,194 shares of the conglomerate’s stock worth $337,000 after purchasing an additional 165 shares during the last quarter. BerganKDV Wealth Management LLC lifted its stake in Danaher by 474.5% during the fourth quarter. BerganKDV Wealth Management LLC now owns 2,752 shares of the conglomerate’s stock worth $422,000 after purchasing an additional 2,273 shares during the last quarter. Rodgers Brothers Inc. bought a new position in Danaher during the fourth quarter worth $203,000. Finally, Savior LLC bought a new position in Danaher during the fourth quarter worth $32,000. 77.88% of the stock is owned by institutional investors and hedge funds.

Several equities analysts recently issued reports on DHR shares. Piper Sandler raised their price objective on Danaher from $142.00 to $174.00 in a research note on Thursday, January 30th. Cowen restated a “buy” rating and set a $170.00 price objective on shares of Danaher in a research note on Monday, February 3rd. Credit Suisse Group raised their price objective on Danaher from $165.00 to $169.00 and gave the stock an “outperform” rating in a research note on Thursday. Royal Bank of Canada raised their target price on Danaher from $159.00 to $173.00 and gave the company an “outperform” rating in a research note on Monday, May 11th. Finally, Zacks Investment Research upgraded Danaher from a “sell” rating to a “hold” rating and set a $160.00 target price on the stock in a research note on Wednesday, April 15th. Six equities research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. The company currently has a consensus rating of “Buy” and an average target price of $168.69.

In other news, Chairman Mitchell P. Rales bought 1,226 shares of the stock in a transaction that occurred on Tuesday, May 12th. The shares were purchased at an average cost of $163.00 per share, with a total value of $199,838.00. Following the completion of the acquisition, the chairman now directly owns 2,236,454 shares in the company, valued at $364,542,002. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, SVP Daniel Raskas sold 37,082 shares of Danaher stock in a transaction dated Friday, May 8th. The stock was sold at an average price of $164.09, for a total value of $6,084,785.38. Following the completion of the transaction, the senior vice president now directly owns 19,723 shares in the company, valued at approximately $3,236,347.07. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 70,974 shares of company stock worth $11,564,444. 11.70% of the stock is owned by corporate insiders.

Shares of DHR traded up $0.60 during trading hours on Friday, reaching $158.26. 1,483,268 shares of the company’s stock traded hands, compared to its average volume of 3,639,653. The firm has a market capitalization of $109.97 billion, a price-to-earnings ratio of 35.97, a P/E/G ratio of 3.56 and a beta of 0.93. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.32 and a quick ratio of 1.01. Danaher Co. has a twelve month low of $119.60 and a twelve month high of $170.64. The business’s fifty day simple moving average is $155.43 and its two-hundred day simple moving average is $151.19.

Danaher (NYSE:DHR) last issued its quarterly earnings results on Wednesday, May 6th. The conglomerate reported $1.05 EPS for the quarter, beating analysts’ consensus estimates of $1.00 by $0.05. The company had revenue of $4.34 billion for the quarter, compared to analyst estimates of $4.32 billion. Danaher had a return on equity of 11.52% and a net margin of 16.85%. The company’s quarterly revenue was up 2.9% compared to the same quarter last year. During the same period last year, the company earned $1.07 earnings per share. On average, equities research analysts expect that Danaher Co. will post 4.88 EPS for the current year.

The company also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be issued a dividend of $0.18 per share. This represents a $0.72 dividend on an annualized basis and a yield of 0.45%. The ex-dividend date of this dividend is Thursday, June 25th. Danaher’s payout ratio is currently 16.29%.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments; Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.

Recommended Story: Why Invest in High-Yield Dividend Stocks?

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.